[In vitro-determination of the cytostatic sensitivity of malignant tumours (author's transl)].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001345:Autoradiography; D002294:Carcinoma, Squamous Cell / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000378:metabolism; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D005350:Fibroma / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D016403:Lymphoma, Large B-Cell, Diffuse / Q000378:metabolism; D008545:Melanoma / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009943:Organophosphorus Compounds; D014316:Tritium; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D013936:Thymidine
Zur Cytostaticasensibilitätsbestimmung maligner Tumoren in vitro.